Keeping up its attack on the Opposition over the COVID-19 vaccine issue, the BJP on Friday said all that its rivals, especially the Congress, have contributed to the matter is "politics and confusion".
BJP spokesperson Sambit Patra hit out at opposition-ruled states like Chhattisgarh, Punjab and Kerala for "refusing" to use the indigenous Covaxin, developed by Bharat Biotech, and said they are playing with the lives of people for their "petty" politics.
On the other hand Prime Minister Narendra Modi has sent out a big message to the world by getting the Covaxin jab, he told reporters here.
"The politics being played in the opposition-ruled states is an insult to the country's scientists and also hurts the 'aatmanirbhar bharat' sentiments," Patra said.
"I want to ask do you not trust scientists and doctors of your country? Over 40 countries have placed order for Covaxin. But in India, we have people doing politics over it for their selfish political interests," the BJP spokesperson said.
Bharat Biotech's Covaxin vaccine, whose emergency use approval before finishing final stage testing had triggered a row, has shown an 81 per cent efficacy in preventing symptomatic COVID-19 disease in an interim analysis of the advanced clinical trial, the company said on Wednesday, boosting prospects of its usage.
Patra alleged that opposition leaders would tease the government by asking why doesn't Prime Minister Modi prove its efficacy by opting for its jab.
Modi did it when his turn came, by following all protocols, he said, noting that President Ram Nath Kovind and Vice President M Venkaiah Naidu also opted for Covaxin.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)